| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5605472 | International Journal of Cardiology | 2017 | 6 Pages |
Abstract
NOAF subsided 6Â weeks after TAVR. AF prevalence and burden decreased significantly over time after SAVR, but remained stable after TAVR. These findings may be considered for post-procedural anti-coagulation strategy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Troels Højsgaard Jørgensen, Hans Gustav Hørsted Thyregod, Julie Bjerre Tarp, Jesper Hastrup Svendsen, Lars Søndergaard,